SCHEMBL23630692

SCHEMBL23630692

O=C(Oc1ccccc1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(OC(=O)c4cc(O)c(O)c(OC(=O)c5cc(O)c(O)c(O)c5)c4)c3)c2)c1

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NSD2 O96028 1/20 0.87
SERPINE1 P05121 3/20 0.72
POLB P06746 2/20 0.70
POLA1 P09884 1/20 0.70
ANTXR2 P58335 1/20 0.70
HPGD P15428 1/20 0.50
ALOX15 P16050 1/20 0.50
HSD17B10 Q99714 1/20 0.50
ALOX5 P09917 1/20 0.50
SELL P14151 1/20 0.50
SELP P16109 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.49
LMNA P02545 2/20 0.46
MAPT P10636 2/20 0.46
TP53 P04637 1/20 0.46
CYP3A4 P08684 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
CHRM1 P11229 1/20 0.46
TBXA2R P21731 1/20 0.46
SLC6A2 P23975 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24265916 1.00 NSD2 (0.87) NSD2SERPINE1POLBPOLA1ANTXR2
SCHEMBL23630687 1.00 NSD2 (0.87) NSD2SERPINE1POLBPOLA1ANTXR2
SCHEMBL26706180 0.95 NSD2 (0.78) NSD2SERPINE1POLBPOLA1ANTXR2
SCHEMBL30257698 0.95 NSD2 (0.78) NSD2SERPINE1POLBPOLA1ANTXR2
SCHEMBL30307951 0.95 NSD2 (0.78) NSD2SERPINE1POLBPOLA1ANTXR2
SCHEMBL2495353 0.93 NSD2 (1.00) NSD2SERPINE1POLBPOLA1ANTXR2
SCHEMBL30257503 0.90 NSD2 (0.71) NSD2SERPINE1POLBPOLA1ANTXR2
SCHEMBL23630707 0.90 NSD2 (0.70) NSD2SERPINE1POLBPOLA1ANTXR2
SCHEMBL23630715 0.90 NSD2 (0.70) NSD2SERPINE1POLBPOLA1ANTXR2
SCHEMBL30257849 0.88 SERPINE1 (0.93) NSD2SERPINE1POLBPOLA1ANTXR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11779561-B2 Compounds and pharmaceutical uses thereof SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) 2023-10-10 US disclosed
US-20210214385-A1 INHIBITORS OF D-AMINO ACID OXIDASE AND USES THEREOF SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) 2021-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210214385-A1 INHIBITORS OF D-AMINO ACID OXIDASE AND USES THEREOF DAO, DDO, DDC NSD2 4322/4885SERPINE1 1124/4885POLB 1656/4885
US-11779561-B2 Compounds and pharmaceutical uses thereof ACE, ACE2, FURIN NSD2 2575/4885SERPINE1 318/4885POLB 2146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.